Physician profile
Tyrone Coyle
NPI 1992237341
$2,067.23
in general payments reported to CMS, 2019-2025
13 companies · $569 in 2025
The $569 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.86 · 2022: $1,113 · 2024: $368 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $858 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.25 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $1,000.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $314.38 | 2021-2025 | Hyqvia, Takhzyro |
| Astrazeneca Pharmaceuticals Lp | $103.85 | 2024-2025 | Airsupra, Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $99.12 | 2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $88.27 | 2025 | |
| Genzyme Corporation | $82.02 | 2025 | |
| Sanofi-Aventis U.S. LLC | $78.99 | 2024 | |
| Csl Behring | $68.49 | 2025 | Andembry |
| Blueprint Medicines Corporation | $64.31 | 2024-2025 | Ayvakit |
| Genentech USA, INC. | $53.20 | 2022-2024 | Xolair |
| Ionis Pharmaceuticals, INC. | $48.28 | 2025 | Dawnzera |
| Ars Pharmaceuticals Operations, INC. | $47.22 | 2025 | Neffy |
| Abbvie INC. | $19.10 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyrone Coyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.